Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | September 25, 2023 01:31pm

Gainers

  • TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday's regular session. TransCode Therapeutics's stock is trading at a volume of 72.3 million shares as of 13:30 EST. This is 12088.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.2 million.
  • Vaccitech (NASDAQ:VACC) shares increased by 82.73% to $3.07. Trading volume for Vaccitech's stock is 18.2 million as of 13:30 EST. This is 135511.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.2 million.
  • Biophytis (NASDAQ:BPTS) shares moved upwards by 71.57% to $1.51. As of 13:30 EST, this security is trading at a volume of 60.8 million shares, making up 13632.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.1 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock rose 25.08% to $0.15. As of 13:30 EST, this security is trading at a volume of 274.7 million shares, making up 818.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.0 million.
  • Cano Health (NYSE:CANO) shares rose 20.05% to $0.27. As of 13:30 EST, Cano Health's stock is trading at a volume of 13.1 million, which is 119.8% of its average full-day volume over the last 100 days. The company's market cap stands at $77.5 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 18.77% to $5.44. Trading volume for Bluejay Diagnostics's stock is 343.4K as of 13:30 EST. This is 28.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million.

Losers

  • Brainstorm Cell (NASDAQ:BCLI) stock decreased by 38.7% to $0.5 during Monday's regular session. Trading volume for Brainstorm Cell's stock is 2.2 million as of 13:30 EST. This is 796.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.5 million.
  • Morphic Holding (NASDAQ:MORF) stock decreased by 32.67% to $24.7. The current volume of 4.7 million shares is 1024.0% of Morphic Holding's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $1.1 billion.
  • SCYNEXIS (NASDAQ:SCYX) stock decreased by 32.03% to $2.25. Trading volume for this security as of 13:30 EST is 3.1 million, which is 962.3% of its average full-day volume over the last 100 days. The company's market cap stands at $83.6 million.
  • Axcella Health (NASDAQ:AXLA) shares declined by 16.62% to $8.63. The current volume of 182.7K shares is 22.4% of Axcella Health's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $25.4 million.
  • MSP Recovery (NASDAQ:LIFW) stock decreased by 15.52% to $0.2. Trading volume for this security as of 13:30 EST is 38.8 million, which is 128.2% of its average full-day volume over the last 100 days. The company's market cap stands at $66.6 million.
  • T2 Biosystems (NASDAQ:TTOO) shares decreased by 12.6% to $0.22. As of 13:30 EST, T2 Biosystems's stock is trading at a volume of 49.6 million, which is 43.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $74.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVTX AXLA BCLI BJDX BPTS CANO LIFW MORF RNAZ SCYX TTOO VACC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist